Institutional investors control 34.14% of the outstanding shares in RPRX. This represents a greater percentage of ownership than at almost any other company in the Medical Specialties industry. Additionally, during the quarter ended March 2016, these large investors purchased a net $1.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACOBS LEVY EQUITY MANAGEMENT, I... Bought 323.4 Thousand shares of Repros Therapeutics Inc
GRUSS CAPITAL MANAGEMENT LP Bought 296.0 Thousand shares of Repros Therapeutics Inc